β blockers for asthma: a double-edged sword

The Lancet

Volumn 373, Issue 9658, 2009, Pages 104-105

  Lipworth, Brian J ^a   Williamson, Peter A ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; NADOLOL; PLACEBO; PROPRANOLOL; SALBUTAMOL;

ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG INDICATION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HEART FAILURE; HUMAN; LOW DRUG DOSE; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; SMOOTH MUSCLE; SYMPATHETIC TONE;

EID: 58149178692     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60018-0     Document Type: Note

References (12)

1. 2-adrenoceptor agonists: a smarter choice for asthma?. Trends Pharmacol Sci 28 (2007) 257-262
2. 2-adrenoceptor antagonism of betaxolol and atenolol. Eur J Clin Pharmacol 40 (1991) 467-471
3. Salpeter S.R., Ormiston T.M., and Salpeter E.E. Cardioselective β-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 137 (2002) 715-725
4. Packer M., Bristow M.R., Cohn J.N., et al., for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
5. Callaerts-Vegh Z., Evans K.L., Dudekula N., et al. Effects of acute and chronic administration of β-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci USA 101 (2004) 4948-4953
6. 2-adrenoceptor and other signaling proteins produced by chronic administration of 'β-blockers' in a murine asthma model. Pulm Pharmacol Ther 21 (2008) 115-124
7. Nguyen L.P., Omoluabi O., Parra S.S., et al. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol 38 (2008) 256-262
8. Hanania N.A., Singh S., El-Wali R., et al. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther 21 (2008) 134-141
9. Currie G.P., Fowler S.J., and Lipworth B.J. Dose response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis. Ann Allergy Asthma Immunol 90 (2003) 194-198
10. 2-agonists as add-on therapy to inhaled corticosteroids. QJM 96 (2003) 435-440
11. Wheeldon N.M., McDevitt D.G., and Lipworth B.J. The effects of lower than conventional doses of nadolol on relative β1/β2-adrenoceptor blockade. Br J Clin Pharmacol 38 (1994) 103-108
12. Ind P.W., Dixon C.M., Fuller R.W., and Barnes P.J. Anticholinergic blockade of beta-blocker induced bronchoconstriction. Am Rev Respir Dis 139 (1989) 1390-1394